Table 1.
Maximum residue limits (MRLs) of mebendazole residues.
Fig 1.
Molecular structures of examined benzimidazoles.
Table 2.
Gradient elution profile.
Table 3.
Summary of diagnostic ions and mass operating parameters.
Fig 2.
Effect of sample purification method on MEB, HMEB, and RMEB recovery in pork spiked at the concentration of 30 μgkg-1.
Fig 3.
Changes in the intensity of MEB, HMEB, and RMEB in pork spiked at the concentration of 30 μgkg-1 with different additives (0.1% Formic acid, 20 mM Ammonium formate, and 10 mM Ammonium formate).
Fig 4.
MS/MS (MS2 scan) spectra of (A) MEB, (B) RMEB, (C) HMEB and (D) IS.
Fig 5.
HPLC-MS/MS chromatograms of (A) standard, (B) pork, (C) chicken, and (D) horse fortified with MEB, RMEB, HMEB, and IS at 30 μgkg-1.
Table 4.
Validation results of the multi-residue method for the determination of mebendazole in pork, chicken, and horse muscles.
Table 5.
Linear regression equations and correlation coefficients of standard curves for mebendazole and its metabolites.
Table 6.
ANOVA results for the linearity of MEB, RMEB, and HMEB.
Table 7.
Summary of purchase region, numbers of collected samples, and mebendazole residues results.